Coupang’s fair value estimate has shifted slightly from US$26.29 to US$25.83, mirroring modest cuts in analyst price targets. The change ties back to recent research where analysts are reworking models for tax and regulatory developments, currency effects and updated earnings assumptions that influence how confident they feel about Coupang’s medium term profile. As you read on, you will see how these price target tweaks fit into the broader bull and bear narrative and what to watch as that...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Goldman Sachs trades at $1,016 and has moved in lockstep with the market. Its shares have returned 8.2% over the last six months while the S&P 500 has gained 8.3%.
Goldman’s chief global equity strategist Peter Oppenheimer said, “There does not appear to be a valuation bubble, but there may be an earnings bubble.”
(Bloomberg) -- Momentum-style equity investing is poised to rebound from a sharp retreat as sectors with strong earnings replace chip stocks in leading the market’s gains, Morgan Stanley strategist Michael Wilson said.Most Read from BloombergTrump Says US to Hold Off Iran Attack If Deal AgreedSaudi Prince Concerned Over Trump’s Iran Strike Plan: AxiosSingapore's Gated Island for the Rich Is Marred by Decayed HomesTrump Says Iran Talks to Begin Monday After Scrapping AttackCrushed by Kospi Rout,
Robinhood Markets (Nasdaq: HOOD) reported its earnings for the second quarter of 2026 on July 29. The brokerage platform, popular for its equity, crypto, and tokenized stock offerings, generated $1.31 billion in revenue and $0.62 in earnings per share (EPS), beating Wall ...
EVR posts record Q2 revenues on stronger deal activity and higher AUM, but rising expenses and special charges weighed on earnings.
Cigna Group will report its earnings on Thursday under its new chief executive, Brian Evanko. It’s transitioning its pharmacy benefits business to a rebate-free model.
AbbVie(ABBV) reports second-quarter results on Friday, July 31, and the mood around the stock has changed. A few months ago, investors were restless. The two drugs carrying the company were doing fine, but everyone already knew that, and the market wanted a new reason to invest. Goldman Sachs went ...
The investment bank is reporting records all around, and shareholders are benefiting.
Earlier in July 2026, Goldman Sachs reported strong second-quarter results, with net income rising to US$6.63 billion and earnings per share roughly doubling year-on-year. Alongside these results, Goldman Sachs intensified capital return and funding actions, including billions in new bond and preferred issuances plus continued buybacks and a higher quarterly dividend. We’ll now examine how this combination of record earnings and increased capital returns might influence Goldman Sachs’...
Wall Street banks are having their best run in over a decade, while Blackstone Inc. (NYSE:BX), heading into its second-quarter earnings today, has missed nearly all of it. Banks Pull Ahead of Private Capital Shares of the largest U.S. private capital groups have slumped more than 15% this year and over 20% in the past […]
JPM, GS and C stand out after strong Q2 results, upbeat 2026 outlooks and improving earnings estimates.
Record revenue and earnings driven by M&A surge and AI infrastructure investment cycle.
Tesla Inc. (NASDAQ:TSLA) released its company-compiled data of sell-side analysts’ forecasts for the automaker’s second-quarter 2026 earnings estimates ahead of this week’s earnings call. Analysts Predict $27 Billion in Revenue On Saturday, the Elon Musk-led automaker announced earnings forecasts from analysts at JP Morgan Chase & Co. (NYSE:JPM), Goldman Sachs Group Inc. (NYSE:GS) and several others. Read Also: This Week in Tesla: Elon Musk Faces Pay Package Questions, US EV Prices Fall and More
Earnings results showed generally solid credit health among borrowers, strong dealmaking activity, and blowout trading numbers.
Q2 earnings season kicked off with the big banks swinging for the fences, and Jefferies sees four dividend-paying giants still leaving serious upside on the table despite the rate uncertainty clouding the second half of 2026.
US banks look like they are trying to move to the upside, but this is a market that has a lot of external influences.
Wall Street cleared this earnings season’s first major hurdle with room to spare, as the nation’s biggest banks pummeled profit forecasts. “Bank earnings are often described as a scoreboard for the financial sector,” said Ruben Dalfovo, investment strategist at Saxo Bank. “They are more useful as an economic medical examination, and the early numbers suggest the patient remains active, and dealmaking appears healthier.”
Morgan Stanley's Q2 earnings surge 62.4% as record equity revenues, stronger IB and $10T in client assets fuel growth. MS raised its quarterly dividend 15%.
Goldman Sachs sees AI infrastructure, large-cap M&A and financing demand driving record Q2'26 results across banking, markets and wealth.
Elevance Health is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday. Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025. The results come just a day ahead of the monster of the industry, UnitedHealth Group Wall Street will be watching to see if these two companies can keep the momentum going.
Goldman Sachs reports record $20.3 billion in revenue and a 25% dividend increase, while navigating market volatility and regulatory challenges.
The Goldman Sachs Group (NYSE:GS) reported record second-quarter 2026 results, with Chairman and Chief Executive Officer David Solomon citing strong client activity, an acceleration in strategic dealmaking and rising demand tied to artificial intelligence infrastructure investment. Goldman generate
Goldman shares were on pace to close at a new high, with shares on Tuesday morning rising 8.6% to $1,136.15 a share--an intraday high--following a record set of second quarter earnings that blew past Wall Street forecasts. The bank posted a record $7.42 billion in stock trading, topping Wall Street’s $5 billion estimate by nearly 50%, as well as $3.4 billion in investment banking fees and $4.59 billion in interest rate trading. Group profits for the three months ending in June were pegged at $20.98 a share, a staggering 92% increase from the same period last year, smashing Wall Street’s forecast of $14.38 a share forecast.
Strong trading, rebounding dealmaking, and higher-rate expectations could support major U.S. bank earnings this quarter.